Publicaciones (70) Publicaciones en las que ha participado algún/a investigador/a

2003

  1. Cyclization of carbonyl groups onto alkynes upon reaction with IPy 2 BF 4 and their trapping with nucleophiles: A versatile trigger for assembling oxygen heterocycles

    Journal of the American Chemical Society, Vol. 125, Núm. 30, pp. 9028-9029

  2. Optimization of the Pharmacophore Model for 5-HT 7 R Antagonism. Design and Synthesis of New Naphtholactam and Naphthosultam Derivatives

    Journal of Medicinal Chemistry, Vol. 46, Núm. 26, pp. 5638-5650

  3. A functionally relevant conformational epitope on the CD9 tetraspanin depends on the association with activated β1 integrin

    Journal of Biological Chemistry, Vol. 278, Núm. 1, pp. 208-218

  4. Anandamide enhances extracellular levels of adenosine and induces sleep: An in vivo microdialysis study

    Sleep, Vol. 26, Núm. 8, pp. 943-947

  5. Apoptosis and necrosis: Two distinct events induced by cadmium in cortical neurons in culture

    British Journal of Pharmacology, Vol. 138, Núm. 5, pp. 901-911

  6. Aspectos genéticos del alcoholismo

    Trastornos adictivos: Organo Oficial de la Sociedad española de Toxicomanías, Vol. 5, Núm. 3, pp. 213-222

  7. Association between cannabinoid receptor gene (CNR1) and childhood attention deficit/hyperactivity disorder in Spanish male alcoholic patients

    Molecular Psychiatry, Vol. 8, Núm. 5, pp. 466-467

  8. Benzimidazole derivatives.4. The recognition of the voluminous substituent attached to the basic amino group of 5-HT4 receptor antagonists

    Journal of Computer-Aided Molecular Design, Vol. 17, Núm. 8, pp. 515-524

  9. CB1 cannabinoid receptors and on-demand defense against excitotoxicity

    Science, Vol. 302, Núm. 5642, pp. 84-88

  10. Ca2+ signalling in brain synaptosomes activated by dinucleotides

    Journal of Membrane Biology, Vol. 194, Núm. 1, pp. 1-10

  11. Cannabinoids: Potential anticancer agents

    Nature Reviews Cancer, Vol. 3, Núm. 10, pp. 745-755

  12. Características farmacológicas de las drogas recreativas (MDMA y otras anfetaminas, Ketamina, GHB, LSD y otros alucinógenos)

    Adicciones: Revista de socidrogalcohol, Vol. 15, Núm. 2, pp. 51-75

  13. Characterization of the 5-hydroxytryptamine receptors mediating contraction in the pig isolated intravesical ureter

    British Journal of Pharmacology, Vol. 138, Núm. 1, pp. 137-144

  14. Co-activation of PKA and PKC in cerebrocortical nerve terminals synergistically facilitates glutamate release

    Journal of Neurochemistry, Vol. 87, Núm. 5, pp. 1101-1111

  15. Co-expression of metabotropic glutamate receptor 7 and N-type Ca2+ channels in single cerebrocortical nerve terminals of adult rats

    Journal of Biological Chemistry, Vol. 278, Núm. 26, pp. 23955-23962

  16. Coexpression of functional P2X and P2Y nucleotide receptors in single cerebellar granule cells

    Journal of Neuroscience Research, Vol. 73, Núm. 3, pp. 384-399

  17. Comparison of prognostic value of atrial fibrillation versus sinus rhythm in patients on long-term hemodialysis

    American Journal of Cardiology, Vol. 92, Núm. 7, pp. 868-871

  18. Compounds acting at the endocannabinoid and/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington's disease

    Journal of Neurochemistry, Vol. 84, Núm. 5, pp. 1097-1109

  19. Design and synthesis of S-(-)-2-[[4-(napht-1-yl)piperazin-1-yl]methyl]-1,4-dioxoperhydropyrrolo[1,2- a]pyrazine (CSP-2503) using computational simulation. A 5-HT1A receptor agonist

    Bioorganic and Medicinal Chemistry Letters, Vol. 13, Núm. 8, pp. 1429-1432

  20. Design and synthesis of new benzimidazole-arylpiperazine derivatives acting as mixed 5-HT1A/5-HT3 ligands

    Bioorganic and Medicinal Chemistry Letters, Vol. 13, Núm. 19, pp. 3177-3180